Inhibitory effects of Hochu-ekki-to on endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17β-estradiol in mice

被引:5
作者
Onogi, Kyoko [1 ]
Niwa, Kenji [1 ]
Tang, Liulin [1 ]
Yun, Wu [1 ]
Mori, Hideki [1 ]
Tamaya, Teruhiko [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Obstet & Gynecol, Gifu 5011194, Japan
关键词
endometrial carcinogenesis; N-methyl-N-nitrosourea; 17; beta-estradiol;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An evaluation of the effects of a traditional Chinese herbal medicine, Hochu-ekki-to (Bu-zong-yi-qi-tang) on endometrial carcinogenesis was performed in experiments with female mice. In the short-term experiment, dietary exposure of Hochu-ekki-to (0.2% for 2 weeks) decreased the estradiol-17 beta (E-2)-stimulated expression levels of c-jun (P < 0.001), tumor necrosis factor (TNF)-alpha (P < 0.005), estrogen receptors (ER)-alpha (P < 0.001) and ER-beta (P < 0.005), as determined by reverse transcription-polymerase chain reaction and a Southern blot analysis in the uteri of the ovarectomized mice. In the long-term experiment, the mice were given N-methyl-N-nitrosourea (MNU) solution (1 mg/100 g body weight) and normal saline (as controls) into their left and right uterine corpora, respectively, and then were divided into four groups. Group 1 (25 mice) was given a diet with Hochu-ekki-to and 5 ppm E-2. Group 2 (25 mice) was given a diet with E-2 alone. Group 3 (25 mice) was given a diet with Hochu-ekki-to alone. Group 4 (25 mice) was kept on the basal diet alone and treated as a control. The incidence of uterine endometrial cancer in the group with Hochu-ekki-to treatment was substantially lower than of the control group. The inhibitory effect of Hochu-ekki-to on endometrial carcinogenesis is thus suggested to decrease the expressions of c-jun, TNF-alpha, ER-alpha and -beta.
引用
收藏
页码:1343 / 1348
页数:6
相关论文
共 31 条
[1]   Loss of ERβ expression as a common step in estrogen-dependent tumor progression [J].
Bardin, A ;
Boulle, N ;
Lazennec, G ;
Vignon, F ;
Pujol, P .
ENDOCRINE-RELATED CANCER, 2004, 11 (03) :537-551
[2]  
CHO J-M, 1991, In Vivo (Attiki), V5, P389
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]  
FRANSEN L, 1985, NUCLEIC ACIDS RES, V13, P185
[5]   Stage-specific expression of estrogen receptor subtypes and estrogen responsive finger protein in preimplantational mouse embryos [J].
Hiroi, H ;
Momoeda, M ;
Inoue, S ;
Tsuchiya, F ;
Matsumi, H ;
Tsutsumi, O ;
Muramatsu, M ;
Taketani, Y .
ENDOCRINE JOURNAL, 1999, 46 (01) :153-158
[6]  
KATAOKA T, 1989, JPN J CANC CHEMOTHER, V16, P1490
[7]  
Kido T, 2000, ANTICANCER RES, V20, P4109
[8]  
KOMORI A, 1993, CANCER RES, V53, P1982
[9]   INDUCTION OF PROTO-ONCOGENE JUN AP-1 BY SERUM AND TPA [J].
LAMPH, WW ;
WAMSLEY, P ;
SASSONECORSI, P ;
VERMA, IM .
NATURE, 1988, 334 (6183) :629-631
[10]  
Lian ZL, 2006, ONCOL REP, V15, P1133